Finance & Investment

Following a record-breaking 2025, Europe's top asset manager is launching a major share buyback to boost shareholder value and signal market confidence.

The real estate giant's mixed cash and stock distribution reveals a strategy to fuel growth amid a nearshoring frenzy, impacting investors and the market.

As OneMain CEO Doug Shulman prepares for a key conference, all eyes are on the lender's strategy for navigating a complex economic and regulatory landscape.

Whitecap Resources adds financial heavyweight Scott Althen to its board as Craig Bryksa departs, signaling a new phase of governance after its massive Veren merger.

Atlanticus Holdings Corp. confirms its quarterly preferred stock dividend, highlighting a rare blend of FinTech innovation with reliable investor returns.

As Erie prepares its 2025 results, investors eye underwriting profit, premium growth, and future guidance in a turbulent insurance market.

With an $80M backlog and a new 'Buy' rating, cybersecurity firm Cycurion looks poised for growth. But can it overcome its volatile past and prove its worth?

January data shows stable job and wage growth for U.S. small businesses, yet persistent labor shortages and rising healthcare costs paint a complex picture.

A new report reveals a widening gap in auto insurance rates. While some states see relief, others face crippling price hikes. Find out why and what you can do.

Record revenue and a bullish forecast overshadowed a massive one-time charge, as the firm's core industrial businesses show powerful underlying strength.

With a challenging year behind them, Hormel's interim leaders will use upcoming events to prove their strategy can restore profitability and win over Wall Street.

Celanese completes a key divestiture to tackle its massive debt, while buyer Element Solutions bolsters its high-growth electronics portfolio.

Following a veteran executive's retirement, Salem Media elevates internal talent to steer key markets through a challenging financial and media landscape.

vTv Therapeutics shores up its finances with a deal worth up to $135M, sharpening its focus on a breakthrough Type 1 diabetes drug, cadisegliatin.

The analytics giant pays down debt and buys back stock, signaling financial health, but faces analyst skepticism over its long-term growth strategy.

Facing default, The Cannabist Company secures a short-term forbearance, highlighting a systemic liquidity crisis threatening the US cannabis industry.

Tevogen Bio's stock surged on news of a potential special dividend, but a closer look reveals a risky promise from a pre-revenue firm facing major hurdles.

Despite a slight dip in annual income, Malaga Bank showcases remarkable stability with pristine credit, robust capital, and continued shareholder dividends.

With new funding, Prometheum accelerates its push to bring crypto and tokenized securities to Wall Street through its unique SEC-compliant infrastructure.

Rio2 completes its transformative acquisition of a major Peruvian copper mine, pivoting from gold to become a diversified Latin American mining force.